tPA supplementation preserves neurovascular and cognitive function in Tg2576 mice
Alzheimer's & Dementia · 2024-07 · 20 (7) · 4572-4582
DOI: 10.1002/alz.13878 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 20.06.2024. Verfasst von Ken Uekawa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, New York, USA. Hauptthemen laut MEDLINE: Tissue Plasminogen Activator, Mice, Transgenic, Cerebrovascular Circulation, Disease Models, Animal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, Feil Family Foundation, NIH HHS.
Abstract (Originalsprache)
INTRODUCTION Amyloid beta (Aβ) impairs the cerebral blood flow (CBF) increase induced by neural activity (functional hyperemia). Tissue plasminogen activator (tPA) is required for functional hyperemia, and in mouse models of Aβ accumulation tPA deficiency contributes to neurovascular and cognitive impairment. However, it remains unknown if tPA supplementation can rescue Aβ‐induced neurovascular and cognitive dysfunction. METHODS Tg2576 mice and wild‐type littermates received intranasal tPA (0.8 mg/kg/day) or vehicle 5 days a week starting at 11 to 12 months of age and were assessed 3 months later. RESULTS Treatment of Tg2576 mice with tPA restored resting CBF, prevented the attenuation in functional hyperemia, and improved nesting behavior. These effects were associated with reduced cerebral atrophy and cerebral amyloid angiopathy, but not parenchymal amyloid. DISCUSSION These findings highlight the key role of tPA deficiency in the neurovascular and cognitive dysfunction associated with amyloid pathology, and suggest potential therapeutic strategies involving tPA reconstitution. Highlights Amyloid beta (Aβ) induces neurovascular dysfunction and impairs the increase of cerebral blood flow induced by neural activity (functional hyperemia). Tissue plasminogen activator (tPA) deficiency contributes to the neurovascular and cognitive dysfunction caused by Aβ. In mice with florid amyloid pathology intranasal administration of tPA rescues the neurovascular and cognitive dysfunction and reduces brain atrophy and cerebral amyloid angiopathy. tPA deficiency plays a crucial role in neurovascular and cognitive dysfunction induced by Aβ and tPA reconstitution may be of therapeutic value.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, New York, USA.
Förderung
- NINDS NIH HHS
- Feil Family Foundation
- NIH HHS
- Cancer Research UK
- BrightFocus Foundation
- Leon Levy Foundation
- National Institutes of Health
Zitieren
APA
Uekawa, K., Anfray, A., Ahn, S. J., Casey, N., Seo, J., Zhou, P., Iadecola, C., & Park, L. (2024). tPA supplementation preserves neurovascular and cognitive function in Tg2576 mice. Alzheimer's & Dementia, 20(7), 4572-4582. https://doi.org/10.1002/alz.13878
Vancouver
Uekawa K, Anfray A, Ahn SJ, Casey N, Seo J, Zhou P, et al. tPA supplementation preserves neurovascular and cognitive function in Tg2576 mice. Alzheimer's & Dementia. 2024;20(7):4572-4582. doi:10.1002/alz.13878
BibTeX
@article{Uekawa2024,
author = {Uekawa, Ken and Anfray, Antoine and Ahn, Sung Ji and Casey, Nicole and Seo, James and Zhou, Ping and Iadecola, Costantino and Park, Laibaik},
title = {tPA supplementation preserves neurovascular and cognitive function in Tg2576 mice},
journal = {Alzheimer's & Dementia},
year = {2024},
volume = {20},
number = {7},
pages = {4572--4582},
doi = {10.1002/alz.13878}
}
EUVIMED